COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND INFLIXIMAB IN PSORIATIC ARTHRITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA

被引：1
|
作者：
Strand, V. [1 ]
McInnes, I. [2 ]
Mease, P. [3 ,4 ]
Choy, E. [5 ]
Nash, P. [6 ]
Thom, H. [7 ]
Kalyvas, C. [8 ]
Gandhi, K. [9 ]
Pricop, L. [9 ]
Jugl, S. [10 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Swedish Med Ctr, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Cardiff Univ, Cardiff, S Glam, Wales
[6] Univ Queensland, Brisbane, Qld, Australia
[7] Univ Bristol, Bristol, Avon, England
[8] MAPI Grp, Houten, Netherlands
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Novartis Pharma AG, Basel, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0480
引用
收藏
页码：957 / 957
页数：1
相关论文
共 50 条
  • [1] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND INFLIXIMAB IN PSORIATIC ARTHRITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Kaul, Arvind
    Strand, Vibeke
    McInnes, Lain
    Mease, Philip
    Choy, Ernest
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    RHEUMATOLOGY, 2018, 57
  • [2] Comparative Effectiveness of Secukinumab and Golimumab in Ankylosing Spondylitis: Assessed By Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data
    Maksymowych, Walter P.
    Choy, Ernest
    Yazici, Yusuf
    Walsh, Jessica A.
    Thom, Howard
    Kalyvas, Chrysostomos
    Fox, Todd
    Gandhi, Kunal
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Maksymowych, W.
    Choy, E.
    Yazici, Y.
    Walsh, J.
    Thom, H.
    Kalyvas, C.
    Fox, T.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1301 - 1301
  • [4] Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Infliximab Using a Matching-Adjusted Indirect Comparison
    Strand, Vibeke
    Mease, Philip J.
    McInnes, Iain B.
    Nash, Peter
    Thom, Howard
    Hunger, Matthias
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Tahir, Hasan
    Maksymowych, Walter
    Choy, Ernest
    Yazici, Yusuf
    Walsh, Jessica
    Thom, Howard
    Kalyvas, Chrysostomos
    Fox, Todd
    Gandi, Kunal
    Jugl, Steffen
    RHEUMATOLOGY, 2018, 57
  • [6] Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on Pivotal Phase 3 Clinical Trial Data
    Maksymowych, Walter
    Strand, Vibeke
    Nash, Peter
    Thom, Howard
    Karabis, Andreas
    Gandhi, Kunal
    Porter, Brian
    Jugl, Steffen
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 914 - 915
  • [7] Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis As Assessed By Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data
    Maksymowych, Walter P.
    Strand, Vibeke
    Nash, Peter
    Thom, Howard
    Karabis, Andreas
    Gandhi, Kunal
    Porter, Brian
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND ADALIMUMAB IN ANKYLOSING SPONDYLITIS AS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON: AN ANALYSIS BASED ON ALL PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Maksymowych, W. P.
    Walsh, J.
    Thom, H.
    Kalyvas, C.
    Rosal, G. F.
    Porter, B.
    Gandhi, K.
    Jugl, S. M.
    VALUE IN HEALTH, 2017, 20 (09) : A935 - A935
  • [9] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND ADALIMUMAB IN ANKYLOSING SPONDYLITIS (AS) AS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC): AN ANALYSIS BASED ON ALL PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Nash, P.
    Maksymowych, W.
    Strand, V
    Thom, H.
    Karabis, A.
    Gandhi, K.
    Porter, B.
    Jugl, S.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 38 - 38
  • [10] Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Choy, Ernest H.
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345